HCRT: Neuropeptides that play a significant role in the regulation of food intake and sleep-wakefulness, possibly by coordinating the complex behavioral and physiologic responses of these complementary homeostatic functions. A broader role in the homeostatic regulation of energy metabolism, autonomic function, hormonal balance and the regulation of body fluids, is also suggested. Orexin-A binds to both OX1R and OX2R with a high affinity, whereas orexin-B binds only to OX2R with a similar high affinity. Defects in HCRT are the cause of narcolepsy type 1 (NRCLP1). Narcolepsy is a neurological disabling sleep disorder, characterized by excessive daytime sleepiness, sleep fragmentation, symptoms of abnormal rapid-eye-movement (REM) sleep, such as cataplexy, hypnagogic hallucinations, and sleep paralysis. Cataplexy is a sudden loss of muscle tone triggered by emotions, which is the most valuable clinical feature used to diagnose narcolepsy. Human narcolepsy is primarily a sporadically occurring disorder but familial clustering has been observed. Human narcolepsy is associated with a deficient orexin system. Orexins are absent and/or greatly diminished in the brain and cerebrospinal fluid (CSF) of most narcoleptic patients. Belongs to the orexin family.
Protein type: Hormone
Chromosomal Location of Human Ortholog: 17q21
Cellular Component: cell junction; cytosol; extracellular region; perinuclear region of cytoplasm; rough endoplasmic reticulum; secretory granule; synaptic vesicle
Molecular Function: type 1 hypocretin receptor binding; type 2 hypocretin receptor binding
Biological Process: eating behavior; elevation of cytosolic calcium ion concentration; G-protein signaling, coupled to IP3 second messenger (phospholipase C activating); negative regulation of DNA replication; negative regulation of potassium ion transport; negative regulation of transmission of nerve impulse; neuropeptide signaling pathway; positive regulation of calcium ion transport; positive regulation of transmission of nerve impulse; protein kinase C activation; regulation of excitatory postsynaptic membrane potential; regulation of neurotransmitter secretion; synaptic transmission
Disease: Narcolepsy 1
Show more